- In March 2024, BIOTRONIK unveiled the world’s first and only comprehensive Conduction System Pacing (CSP) solution, now fully CE-approved for Left Bundle Branch Area Pacing (LBBAP). This system integrates three trusted components: Selectra 3D catheters known for their exceptional handling, Solia S leads – the leading choice of stylet-driven leads for LBBAP, offering superior stability, and the Amvia pacemaker family, the only pacemaker series approved for LBBAP
- In October 2022, Medtronic plc, a global healthcare technology leader, announced U.S. Food and Drug Administration (FDA) approval for the expanded labeling of a cardiac lead designed to utilize the heart's natural electrical conduction system. This innovation, often called "conduction system pacing," delivers therapy that closely mirrors the heart's natural contractions, minimizing complications associated with traditional pacing methods, such as cardiomyopathy, and promoting synchronized ventricular function
Frequently Asked Questions
The market is segmented based on Segmentation, By Diagnosis (Electrocardiogram and Echocardiogram), Causes (High Blood Pressure, Heart Failure, and Others) – Industry Trends and Forecast to 2032
.
The Global Bundle Branch Block Market size was valued at USD 1.68 USD Billion in 2024.
The Global Bundle Branch Block Market is projected to grow at a CAGR of 5.6% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
